The Supreme Court is reentering the abortion debate with a case centered around mifepristone. The Food and Drug Administration approved the abortion pill in 2000 and made changes that expanded access to the drug in following years. Now, a group of anti-abortion doctors is challenging the FDA’s changes. Amy Howe covers the Supreme Court. She joins Soledad O’Brien in-studio to discuss how the case could affect access to abortion medication and the FDA’s approval process.

Related Videos